Cervical neoplasia and human papilloma virus infection as risk factors for the development of anal cancer and precursor lesions
DOI:
https://doi.org/10.29059/cienciauat.v17i2.1756Keywords:
human papillomavirus, anal cancer, cervical neoplasiaAbstract
The incidence of anal cancer has increased in the last 10 years, especially in the population considered to be at risk. Women with a history of infection in the genital tract by Human Papillomavirus (HPV) have higher risk of developing this type of cancer. The presence of high-risk (HR) HPV genotypes in the anogenital region has been shown to play a role in the etiopathogenesis of anal cancer. Many aspects of the natural history of anal lesions are unknown, but the anal transition zone is considered to have a high cell replacement. This is why a pathophysiological mechanism of HR-HPV infection and development of invasive lesions similar to those of cervical cancer has been suggested. The aim of this work was to show the current status of the epidemiological information that links the risk of developing anal cancer in women with cervical cancer precursor lesions associated with HPV infection. The relevance of this information is to provide a basis of recommendations for the timely detection of anal cancer in women considered to be at HR of suffering it, and to encourage more prospective studies in this population.
References
Aguiar, C., García, L., Boccardo, B, M., Vassel, M., Arriola, A., Jaumandreu, S., …, and Heard, I. (2020). Anal PAP, HPV tests and magnifying chromoendoscopy with biopsies in the diagnosis of anal intraepithelial neoplasia. Journal of Coloproctology. 40(3): 220-226. DOI: https://doi.org/10.1016/j.jcol.2020.05.003
Aguiar, C., Jaumandreu, S., Álvarez, C. y Rodríguez, M. C. (2018). Uso de la cromoendoscopía digestiva con magnificación en el diagnóstico de la neoplasia intraepitelial anal. Acta Gastroenterología Latinoamérica. 48(3): 206-212.
Alarcón-Romero, L. D. C., Organista-Nava, J., Gómez-Gómez, Y., Ortiz-Ortiz, J., Hernández-Sotelo, D., Del-Moral-Hernández, O., …, and Gómez-Gómez, Y. (2022). Prevalence and distribution of Human Papillomavirus genotypes (1997–2019) and their association with cervical cancer and precursor lesions in women from southern Mexico. Cancer Control. 29: 10732748221103331. DOI: https://doi.org/10.1177/10732748221103331
Alemany, L., Saunier, M., Alvarado-Cabrero, I., Quirós, B., Salmeron, J., Shin, H. R., …, de-Sanjosé, S. (2015). Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. International Journal of Cancer. 136(1): 98-107. DOI: https://doi.org/10.1002/ijc.28963
Benevolo, M., Latini, A., Rollo, F., Giuliani, M., Giglio, A., Giuliani, E., …, and Donà, M. G. (2022). Incidence of abnormal anal cytology in HIV-infected and HIV-uninfected men who have sex with men. Cancer Cytopathol. A head of print. DOI: https://doi.org/10.1002/cncy.22675
Bertoli, H. K., Thomsen, L. T., Iftner, T., Dehlendorff, C., and Kjær, S. K. (2020). Risk of vulvar, vaginal, and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study. Gynecologic Oncology. 157(2): 456-462. DOI: https://doi.org/10.1016/j.ygyno.2020.01.030
Brum, V. O. R., Tricoti, A. S. O., Pannain, G. D., Drumond, D. G., and Leite, I. C. G. (2022). Cytology-based Screening for Anal Intraepithelial Neoplasia in Immunocompetent Brazilian Women with a History of High-Grade Cervical Intraepithelial Neoplasia or Cancer. Revista Brasileira de Ginecologia e Obstetricia. 44(7): 678–685. DOI: https://doi.org/10.1055/s-0042-1743163
CDC, Centros para el Control y Prevención de Enfermedades (2020). Tasas del cáncer anal asociado al VPH por raza y grupo étnico | CDC. Base de datos SEER*Stat del Programa Nacional de Registros del Cáncer: Archivo analítico de incidencia, en Informe Estadísticas del Cáncer en los Estados Unidos, 1998–2017. [En línea]. Disponible en: https://www.cdc.gov/spanish/cancer/hpv/statistics/anal.htm. Fecha de consulta: 5 de agosto de 2022.
Ciombor, K. K., Ernst, R. D., and Brown, G. (2017). Diagnosis and diagnostic imaging of anal canal cancer. Surgical Oncology Clinics. 26(1): 45-55. DOI: https://doi.org/10.1016/j.soc.2016.07.002
Clifford, G. M., Georges, D., Shiels, M. S., Engels, E. A., Albuquerque, A., Poynten, I. M., …, and Stier, E. A. (2021). A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. International Journal of Cancer. 148(1): 38-47. DOI: https://doi.org/10.1002/ijc.33185
Coffey, K., Beral, V., Green, J., Reeves, G., and Barnes, I. (2015). Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years. British Journal of Cancer. 112(9): 1568-1574. DOI: https://doi.org/10.1038/bjc.2015.89
Cronin, B., Bregar, A., Luis, C., Schechter, S., Disilvestro, P., Pisharodi, L., …, and Robison, K. (2016). Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy. Gynecologic Oncology. 141(3): 492-496. DOI: https://doi.org/10.1016/j.ygyno.2016.04.015
Della-Fera, A. N., Warburton, A., Coursey, T. L., Khurana, S., and McBride, A. A. (2021). Persistent Human Papillomavirus Infection. Viruses. 13(2): 321. DOI: https://doi.org/10.3390/v13020321
De-Martel, C., Plummer, M., Vignat, J., and S. (2017). Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer. 141(4): 664-670. DOI: https://doi.org/10.1002/ijc.30716
DOF, Diario Oficial de la Federación (2007). Modificación a la Norma Oficial Mexicana NOM-014-SSA2-1994. Para la prevención, detección, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer cérvico uterino. Diario Oficial de la Federación. Secretaria de Salud. 52-70.
Donaire, C., Reillo, M., Martínez-Escoriza, J. C., and López-Fernández, J. A. (2017). Anal study in immuno-competent women with human papillomavirus related lower genital tract pathology. European Journal of Obstetrics and Gynecology and Reproductive Biology. 211: 25-20. DOI: https://doi.org/10.1016/j.ejogrb.2017.01.023
Elfström, K. M., Eklund, C., Lamin, H., Öhman, D., Hortlund, M., Elfgren, K., …, and Dillner J. (2021). Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trial. PLoS Med. 18(8): e1003748. DOI: https://doi.org/10.1371/journal.pmed.1003748
Elorza, G., Saralegui, Y., Enríquez-Navascués, J. M., Placer, C., and Velaz, L. (2016). Neoplasia intraepitelial anal: una revisión de conjunto. Revista Española de Enfermedades Digestivas. 108(1): 31-39.
Erazo-Luna, E. V. and Velásquez-Lopera, M. M. (2019). Immunological response to human papilloma virus. Dermatología Revista Mexicana. 63(1): 40-59.
Fraga-Campo, S. (2010) HPV. Cribado de cáncer de cérvix Vacunación. [En línea]. Disponible en: https://www.quironsalud.es/es/comunicacion/agenda-eventos/1-jornada-ginecologia-obstetricia-atencion-primaria.ficheros/461053cribado%20cáncer%20cervix.%20VPH.%20Vacuna.pdfPT. Fecha de consulta: 5 de agosto de 2022.
Globocan (2020). México. The Global Cancer Observatory. International Agency for Research on Cancer, in World Health Organization. [En línea]. Disponible en: https://gco.iarc.fr/today/data/factsheets/populations/484-mexico-fact-sheets.pdf. Fecha de consulta: 10 de agosto de 2022.
González-Losa, M. R., Puerto-Solís, M., Ayora-Talavera, G., Gómez-Carvallo, J., Euán-López, A., Cisneros-Cutz, J. I., …, and Conde-Ferráez, L. (2016). Prevalence of anal infection due to high-risk human papillomavirus and analysis of E2 gene integrity among women with cervical abnormalities. Enfermedades Infecciosas y Microbiología Clínica. 36(4): 209-213. DOI: https://doi.org/10.1016/j.eimc.2016.11.010
Hernández-Hernández, D. M., Patlán-Pérez, R. Ma., y Apresa-García, T. (2015). Panorama epidemiológico del cáncer cervicouterino. Revista Médica del Instituto Mexicano del Seguro Social. 53(2): S154-161.
INCAN, Instituto Nacional de Cancerología (2016). Programa Integral de Prevención y Control del Cáncer en México. [En línea]. Disponible en: https://www.iccp-portal.org/system/files/plans/PICCM_FINALINCan_Enero2018.pdf. Fecha de consulta: 25 de enero de 2023.
INEGI, Instituto Nacional de Estadística y Geografía (2021). Estadísticas a propósito del día mundial contra el cáncer. Datos nacionales, en Comunicado de prensa núm. 105/21. [En línea]. Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2021/cancer2021_Nal.pdf. Fecha de consulta: 10 de agosto de 2022.
Khattab, R., McMeekin, E., Taege, A. J., Hekman, J. M., Brainard, J. A., Underwood, D., …, and Sturgis, C. D. (2018). Unsatisfactory exfoliative anal cytology samples, 15-year experience with histologic, cytologic, and molecular follow-up. Diagnostic Cytopathology. 46(2): 117-121. DOI: https://doi.org/10.1002/dc.23858
Krzowska-Firych, J., Lucas, G., Lucas, C., Lucas, N., and Pietrzyk, Ł. (2019). An overview of Human Papillomavirus (HPV) as an etiological factor of the anal cancer. Journal of Infection and Public Health. 12(1): 1-6. DOI: https://doi.org/10.1016/j.jiph.2018.06.005
Lammé, J., Pattaratornkosohn, T., Mercado-Abadie, J., Alkhas, A., Robinson, A., and Lanneau, G. (2014). Concurrent anal human papillomavirus and abnormal anal cytology in women with known cervical dysplasia. Obstetrics and Gynecology. 124(2 Pt 1): 242-248. DOI: https://doi.org/10.1097/AOG.0000000000000370
Latan, J., Fernandes, A., López, M., Fermín, M., and Correnti, M. (2017). Detección de la infección por virus de papiloma humano en ano en pacientes con lesiones en cuello uterino. Revista de Obstetricia y Ginecología de Venezuela. 77(2): 92-99.
Lin, C., Slama, J., Gonzalez, P., Goodman, M. T., Xia, N., Kreimer, A. R., …, and Clifford, G. M. (2019). Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. The Lancet Infectious Diseases. 19(8): 880-891. DOI: https://doi.org/10.1016/S1473-3099(19)30164-1
Mayer, R. J. (2019). Cánceres de tubo digestivo bajo, en Harrison. Principios de Medicina. [En línea]. Disponible en: Interna. https://accessmedicina.mhmedical.com/contentaspx?bookid=1717§ionid=114915201. Fecha de consulta: 10 de agosto de 2022.
Moscicki, A. B., Darragh, T. M., Berry-Lawhorn, J., Roberts, J. M., Khan, M. J., Boardman, L. A., …, and Palefsky, J. M. (2015). Screening for anal cancer in women. Journal of Lower Genital Tract Disease. 19(3): S27–S42. DOI: https://doi.org/10.1097/LGT.0000000000000117
Nasioutziki, M., Chatzistamatiou, K., Loufopoulos, P. D., Vavoulidis, E., Tsampazis, N., Pratilas, G. C., …, and Dinas, K. (2020). Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy. Infectious Agents and Cancer. 15(1): 15-22. DOI: https://doi.org/10.1186/s13027-020-00287-7
National Cancer Institute (2019). SEER Cancer Stat Facts. [En línea]. Disponible en: https://seer.cancer.gov/statfacts/html/mulmy.html. Fecha de consulta: 10 de agosto de 2022.
Nelson, V. M. and Benson, A. B. (2017). Epidemiology of anal canal cancer. In Surgical Oncology Clinics of North America. 26(1): 9-15. DOI: https://doi.org/10.1016/j.soc.2016.07.001
Ortiz-Bautista, R. J. y Méndez-Cano, V. H. (2018). Tamizaje por citología de lesiones preneoplásicas del conducto anal. Patología Revista Latinoamericana. 56(4): 303-309.
Padilla-España, L., Repiso-Jiménez, J. B., Fernández-Sánchez, F., Pereda, T., Rivas-Ruiz, F., Fernández-Morano, T., …, and de-Troya-Martín, M. (2016). Efectividad del genotipado del virus del papiloma humano frente a la citología anal en la identificación de neoplasia intraepitelial de alto grado. Enfermedades Infecciosas y Microbiologia Clinica. 34(7): 400-405. DOI: https://doi.org/10.1016/j.eimc.2016.02.003
Pangarkar, M. A. (2022). The Bethesda System for reporting cervical cytology. Cytojournal. 19: 28. DOI: https://doi.org/10.25259/CMAS_03_07_2021
Ramírez-Padilla, M., Ruiz-López, P., and de-Aguinaga-Inurriaga, A. E. (2020). Virus del papiloma humano y condilomatosis anogenital. Dermatología Cosmética, Médica y Quirúrgica. 18(3): 215-227.
Sánchez-Corredor, C. D., Guerrero-Machado, M., Rubio-Romero, J. A., Diaz-Cruz, L. A., Angel-Muller, E., and Rey-Serrano, G. (2020). Prevalence of high-risk human papilloma virus infection and abnormal cytology of the anal transformation zone in women with cervical dysplasia. Revista Colombiana de Obstetricia y Ginecología. 71(4): 345-355. DOI: https://doi.org/10.18597/rcog.3558
Sand, F. L., Munk, C., Jensen, S. M., Svahn, M. F., Frederiksen, K., and Kjær, S. K. (2016). Long-term risk for noncervical anogenital cancer in women with previously diagnosed high-grade cervical intraepithelial neoplasia: A Danish nationwide cohort study. Cancer Epidemiology Biomarkers and Prevention. 25(7): 1090-1097. DOI: https://doi.org/10.1158/1055-9965.EPI-15-1291
Santos-López, G., Márquez-Domínguez, L., Reyes-Leyva, J., y Vallejo-Ruiz, V. (2015). Aspectos generales de la estructura, la clasificación y la replicación del virus del papiloma humano. Revista Mexicana del Seguro Social. 53(S2): 166-171.
Sehnal, B., Dusek, L., Cibula, D., Zima, T., Halaska, M., Driak, D., and Slama, J. (2014). The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia. Journal of Clinical Virology. 59(1): 18-23. DOI: https://doi.org/10.1016/j.jcv.2013.11.004
Sendagorta-Cudós, E., Burgos-Cibrián, J., and Rodríguez-Iglesias, M. (2019). Genital infections due to the human papillomavirus. Enfermedades Infecciosas y Microbiología Clinica. 37(5): 324-334. DOI: https://doi.org/10.1016/j.eimce.2019.01.003
Shiels, M. S., Kreimer, A. R., Coghill, A. E., Darragh, T. M., and Devesa, S. S. (2015). Anal cancer incidence in the United States, 1977-2011: Distinct patterns by histology and behavior. Cancer Epidemiology Biomarkers and Prevention. 24(10): 1548-1556. DOI: https://doi.org/10.1158/1055-9965.EPI-15-0044
Simpson, S., Blomfield, P., Cornall, A., Tabrizi, S. N., Blizzard, L., and Turner, R. (2016). Front-to-back & dabbing wiping behaviour post-toilet associated with anal neoplasia & HR-HPV carriage in women with previous HPV-mediated gynaecological neoplasia. Cancer Epidemiology. 42: 124-132. DOI: https://doi.org/10.1016/j.canep.2016.04.001
Stier, E. A. and Chiao, E. Y. (2017). Anal cancer and anal cancer precursors in women with a history of HPV-related dysplasia and cancer. Seminars in Colon and Rectal Surgery. 28(2): 97-101. DOI: https://doi.org/10.1053/j.scrs.2017.04.008
Stier, E. A., Sebring, M. C., Mendez, A. E., Ba, F. S., Trimble, D. D., and Chiao, E. Y. (2015). Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: A systematic review. American Journal of Obstetrics and Gynecology. 213(3): 278-309. DOI: https://doi.org/10.1016/j.ajog.2015.03.034
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer Journal for Clinicians. 71(3): 209-249. DOI: https://doi.org/10.3322/caac.21660
Torres-Poveda, K., Piña-Sánchez, P., Vallejo-Ruiz, V., Lizano, M., Cruz-Valdez, A., Juárez-Sánchez, P., …, and Manzo-Merino, J. (2020). Molecular markers for the diagnosis of high-risk human papillomavirus infection and triage of human papillomavirus-positive women. Revista de I nvestigacion Clinica. 72(4): 198-212. DOI: https://doi.org/10.24875/RIC.20000058
Viens, L. J., Henley, S. J., Watson, M., Markowitz, L. E., Thomas, C. C., Thompson, T. D., …, and Saraiya, M. (2016). Human Papillomavirus–Associated Cancers — United States, 2008–2012. Morbidity and Mortality Weekly Report. 65(26): 661-666. DOI: https://doi.org/10.15585/mmwr.mm6526a1
Wohlmuth, C., Ghorab, Z., Shier, M., Tinmouth, J., Salit, I. E., Covens, A., …, and Vicus, D. (2021). Cytology-based screening for anal intraepithelial neoplasia in women with a history of cervical intraepithelial neoplasia or cancer. Cancer Cytopathology. 129(2): 140-147. DOI: https://doi.org/10.1002/cncy.22360
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Universidad Autónoma de Tamaulipas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
